Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.
Toyoda K, Koga M, Iguchi Y, Itabashi R, Inoue M, Okada Y, Ogasawara K, Tsujino A, Hasegawa Y, Hatano T, Yamagami H, Iwama T, Shiokawa Y, Terayama Y, Minematsu K. Toyoda K, et al. Among authors: tsujino a. Neurol Med Chir (Tokyo). 2019 Dec 15;59(12):449-491. doi: 10.2176/nmc.st.2019-0177. Epub 2019 Dec 5. Neurol Med Chir (Tokyo). 2019. PMID: 31801934 Free PMC article. No abstract available.
Impact of width of susceptibility vessel sign on recanalization following endovascular therapy.
Kanamoto T, Tateishi Y, Yamashita K, Furuta K, Torimura D, Tomita Y, Hirayama T, Shima T, Nagaoka A, Yoshimura S, Miyazaki T, Ideguchi R, Morikawa M, Morofuji Y, Horie N, Izumo T, Tsujino A. Kanamoto T, et al. Among authors: tsujino a. J Neurol Sci. 2023 Mar 15;446:120583. doi: 10.1016/j.jns.2023.120583. Epub 2023 Feb 12. J Neurol Sci. 2023. PMID: 36827810
Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
Saji N, Kimura K, Tateishi Y, Fujimoto S, Kaneko N, Urabe T, Tsujino A, Iguchi Y; daVinci Study Group. Saji N, et al. Among authors: tsujino a. J Thromb Thrombolysis. 2016 Nov;42(4):453-62. doi: 10.1007/s11239-016-1376-x. J Thromb Thrombolysis. 2016. PMID: 27207691 Clinical Trial.
Large aortic arch plaques correlate with CHADS2 and CHA2DS2-VASc scores in cryptogenic stroke.
Ueno Y, Tateishi Y, Doijiri R, Kuriki A, Shimizu T, Kikuno M, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Hattori N, Urabe T. Ueno Y, et al. Among authors: tsujino a. Atherosclerosis. 2019 May;284:181-186. doi: 10.1016/j.atherosclerosis.2019.03.009. Epub 2019 Mar 20. Atherosclerosis. 2019. PMID: 30921601
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS Investigators. Aoki J, et al. Among authors: tsujino a. J Am Heart Assoc. 2019 Aug 6;8(15):e012652. doi: 10.1161/JAHA.119.012652. Epub 2019 Jul 26. J Am Heart Assoc. 2019. PMID: 31347430 Free PMC article. Clinical Trial.
National trends in outcomes of ischemic stroke and prognostic influence of stroke center capability in Japan, 2010-2016.
Kada A, Ogasawara K, Kitazono T, Nishimura K, Sakai N, Onozuka D, Shiokawa Y, Miyachi S, Nagata I, Toyoda K, Hashimoto Y, Hasegawa Y, Hoshino H, Yoshimura S, Suzuki M, Tsujino A, Matsuda S, Kurogi R, Kurogi A, Ren N, Nishimura A, Arimura K, Hagihara A, Tominaga T, Kayama T, Arai H, Suzuki N, Miyamoto S, Ogawa A, Iihara K; J-ASPECT Study Collaborators. Kada A, et al. Among authors: tsujino a. Int J Stroke. 2019 Oct 25:1747493019884526. doi: 10.1177/1747493019884526. Online ahead of print. Int J Stroke. 2019. PMID: 31653178
Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke.
Kikuno M, Ueno Y, Shimizu T, Kuriki A, Tateishi Y, Doijiri R, Shimada Y, Takekawa H, Yamaguchi E, Koga M, Kamiya Y, Ihara M, Tsujino A, Hirata K, Toyoda K, Hasegawa Y, Aizawa H, Hattori N, Urabe T; CHALLENGE ESUS/C.S. collaborators. Kikuno M, et al. Among authors: tsujino a. J Neurol. 2020 May;267(5):1482-1490. doi: 10.1007/s00415-020-09732-4. Epub 2020 Feb 3. J Neurol. 2020. PMID: 32016623
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic stroke.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS investigators. Aoki J, et al. Among authors: tsujino a. J Neurol Sci. 2020 Jun 15;413:116796. doi: 10.1016/j.jns.2020.116796. Epub 2020 Mar 21. J Neurol Sci. 2020. PMID: 32222589 Clinical Trial.
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
Koga M, Yamamoto H, Inoue M, Asakura K, Aoki J, Hamasaki T, Kanzawa T, Kondo R, Ohtaki M, Itabashi R, Kamiyama K, Iwama T, Nakase T, Yakushiji Y, Igarashi S, Nagakane Y, Takizawa S, Okada Y, Doijiri R, Tsujino A, Ito Y, Ohnishi H, Inoue T, Takagi Y, Hasegawa Y, Shiokawa Y, Sakai N, Osaki M, Uesaka Y, Yoshimura S, Urabe T, Ueda T, Ihara M, Kitazono T, Sasaki M, Oita A, Yoshimura S, Fukuda-Doi M, Miwa K, Kimura K, Minematsu K, Toyoda K; THAWS Trial Investigators. Koga M, et al. Among authors: tsujino a. Stroke. 2020 May;51(5):1530-1538. doi: 10.1161/STROKEAHA.119.028127. Epub 2020 Apr 6. Stroke. 2020. PMID: 32248771 Free PMC article. Clinical Trial.
142 results